Comparison

CCT196969

Item no. DCC-DC10005-100mg
Manufacturer DCChemicals
CASRN 1163719-56-9
Amount 100 mg
Quantity options 100 mg 1 g 250 mg
Category
Type Inhibitors
Specific against other
Purity >98%
Smiles FC1C([H])=C(C([H])=C([H])C=1N([H])C(N([H])C1=C([H])C(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])=NN1C1C([H])=C([H])C([H])=C([H])C=1[H])=O)OC1C([H])=C([H])N=C2C=1N=C([H])C(N2[H])=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias CCT196969; CCT-196969; CCT 196969
Similar products 1163719-56-9
Available
Manufacturer - Applications
CCT196969 is a novel orally available, pan-RAF inhibitor with anti-SRC activity.
Storage Conditions
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight
513, 523
Note
For research only, not for human use.
Chemical name
1-(3-(tert-butyl)-1-phenyl-1H-pyrazol-5-yl)-3-(2-fluoro-4-((3-oxo-3, 4-dihydropyrido[2, 3-b]pyrazin-8-yl)oxy)phenyl)urea

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close